In a previous study, the counting efficiency calibration was calculated for 36 computational mesh phantoms called MaMP and FeMP-Male and Female Mesh Phantoms, which span variations in height, weight and gender. They were created to be used in a sitting configuration WBC set-up using an HPGe detector. Now this work is extended to investigate the influence of body sizes and the position of the detector on the counting efficiency (CE) for a different counting geometry. This was done by creating a new set of MaMP and FeMP mesh phantoms lying on a reclining chair and by studying the variation of the counting efficiency using a NaI(Tl) detector for the WBC set-up of SCK-CEN. The deviation of the CE due to the detector's position with respect to the phantom was investigated. Correlations were also studied for CE as a function of trunk volume, waist-hips ratio (WHR) and waist-chest ratio (WCR) for different mesh phantoms.
Fluence to dose equivalent conversion coefficients provide the basis for the calculation of area and personal monitors. Recently, the ICRP has started a revision of these coefficients, including new Monte Carlo codes for benchmarking. So far, little information is available about neutron transport below 10 MeV in tissue-equivalent (TE) material performed with Monte Carlo GEANT4 code. The objective of this work is to calculate neutron fluence to personal dose equivalent conversion coefficients, Hp (10)/ϕ, with GEANT4 code. The incidence of monoenergetic neutrons was simulated as an expanded and aligned field, with energies ranging between thermal neutrons to 10 MeV on the ICRU slab of dimension 30 x 30 x 15 cm 3 , composed of 76.2% of oxygen, 10.1% of hydrogen, 11.1% of carbon and 2.6% of nitrogen. For all incident energy, a cylindrical sensitive volume is placed at a depth of 10 mm, in the largest surface of the slab (30 x 30 cm 2 ). Physic process are included for neutrons, photons and charged particles, and calculations are made for neutrons and secondary particles which reach the sensitive volume. Results obtained are thus compared with values published in ICRP 74. Neutron fluence in the sensitive volume was calculated for benchmarking. The Monte Carlo GEANT4 code was found to be appropriate to calculate neutron doses at energies below 10 MeV correctly.
An individual albedo neutron dosimeter is simulated with the Geant4 toolkit. The simulation results are compared with results from an international intercomparison for Monte Carlo codes. The doses are obtained for thermoluminescent dosimeters irradiated free in the air and also on the surface of a water phantom for different neutron energy values. The Geant4 toolkit was not used by any of the participants in this intercomparison, so with these results we can infer the applicability of Geant4 in radiation protection for this type of simulation in neutron fields.
The objective of this work is to obtain fluence to effective dose conversion coefficients for neutron point sources, using the GEANT4 toolkit. These calculations aim to investigate the aspects of neutron transport in the human body through Monte Carlo simulation using the International Commission on Radiological Protection (ICRP) voxel phantoms, described in its publication 110. A benchmarking of the code was made for the case of monoenergetic plane parallel neutron beam in the antero-posterior (AP) irradiation geometry and organ absorbed dose conversion coefficients were compared with those found in the ICRP publication 116. The results showed good agreement with ICRP results in the studied energy range. Conversion coefficients were presented for specific conditions with 241Am-Be and 252Cf point neutron sources 1 m away from the phantom in the AP geometry.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.